Molecular Biology

J.H. Exton, "Signaling through phosphatidylcholine breakdown," The Journal of Biological Chemistry, 265, 1-4, 5 January 1990. John H. Exton (Vanderbilt University School of Medicine, Nashville, Tenn.): "This article was designed to alert readers to the existence of what appears to be a novel cellular signaling system involving the breakdown of phosphatidylcholine to phosphatidic acid. It arose out of the realization that the accumulation of phosphatidic acid in stimulated cells could not be e

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

J.H. Exton, "Signaling through phosphatidylcholine breakdown," The Journal of Biological Chemistry, 265, 1-4, 5 January 1990.

John H. Exton (Vanderbilt University School of Medicine, Nashville, Tenn.): "This article was designed to alert readers to the existence of what appears to be a novel cellular signaling system involving the breakdown of phosphatidylcholine to phosphatidic acid. It arose out of the realization that the accumulation of phosphatidic acid in stimulated cells could not be explained by the `in vogue' phosphoinositide hypothesis. The phosphoinositide gurus were not happy to see this upstart hypothesis, and this `hot' topic initially received a very `cold' reception! Although the system has many of the hallmarks of being involved in signal transduction, its significance in cell physiology is still very unclear. For example, many investigators believe that phosphatidic acid is an important signal in cells, but don't know why. I think that the system has attracted attention because ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies